Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Can you provide a link to the article that you are referencing as a must read?
Just an FYI, 4 more EUA follow-ups by the FDA, all for antibody detection and all to be done in authorized laboratories.
2/25, 2/28, 3/1, 3/1
https://www.fda.gov/medical-devices/coronavirus-disease-2019-covid-19-emergency-use-authorizations-medical-devices/in-vitro-diagnostics-euas-serology-and-other-adaptive-immune-response-tests-sars-cov-2
Interestingly, the following disqualifier appears on each letter, and all have been "signed" by the same individual:
Yesterday's volume of NVAC was 797,589 shares traded, and finished off at 1 penny below the 52-week high of $9.84
Roughly speaking, almost $8 million worth of stock traded hands.
And yet, lol, only 2 shares of NVACR sold for just over 26 cents...to me!
I don't know if that is good or bad, but for the first time in my life, I actually bought 100% of the shares traded for a company in a single day.
I do still stick with my belief that now the big boys are focused on consolidating and trading the stock, rather than "pussy footing around" with the "penny-stock" options...
...and that the options are where the biggest ROIs will be found...
Great video background on Axim, not my find, but I wanted to clear up the post and put the emphasis instead on the video itself:
My calculations would be the same as yours.
For every $10 million in NET revenues, the pps would be worth about $1, using an average P/E of 15.
But the DED line of test kits are in themselves quite impressive, and they are set to be sold worldwide, which makes that $30 million target "a drop in the bucket."
One of the two tests measures the levels of Lactoferrin in tear drops, using this biomarker as a sign of Dry Eye Disease (and when used in conjunction with the other patented DED test kit that AXIM has, makes the diagnosis extremely accurate - and both tests are inexpensive, give rapid, 10 to 15 minute results, right at the doctor's office)(which is a game-changer when it comes to DED diagnosis).
I don't think anyone will ever get Americans back in masks over a virus ever again, especially when, "Two weeks to flatten the curve" turned into 2 years of unnecessary lockdowns, unfounded mask directives, and unconstitutional vaccine mandates.
Keep in mind, there still is a truckers convoy headed to Washington, D.C.
Besides, the Russian invasion into the Ukraine has more than created enough of a distraction to keep the general population from seeing what Durham has been doing lately.
Personally, I'm thinking that now that the planned-demic is no longer useful to those politically in control, that there is no longer a motivation to oppose the issuance of an EUA for Immunopass.
THAT, coupled with the FDA's recent corruption exposure which may force the FDA to now try to make their process look more legitimate, could make an EUA for Immunopass more of a possibility.
We may be on our way out of that portion of the rollercoaster ride that is unpleasant and painful, and headed to the part where the ride is faster, less jarring, and so much more enjoyable.
Regardless of the near-term future of Immunopass, I still feel that the DED line will bring AXIM to $2.50 to $3 by year end - not a bad ROI for anyone averaged in at 50 cents or below.
Godspeed, and welcome back.
Hope your trip East and back home was a satisfying and productive one.
Just an FYI, but the FDA has NOT issued an In Vitro Diagnostics EUA (which is what Immunopass would be considered) since February 14th!
I wonder if this has anything to do with the extremely damning Project Veritas videos that were released on February 16th (exposing corrupt practices going on within the FDA).
Project Veritas completely exposed the FDA for illegally colluding with vaccine makers.
— Kαƚყ🕊🌻🎨 (@Katy30770035) February 16, 2022
The FDA responded by lying and saying it isn't their employee. pic.twitter.com/bAQg1SrTWb
Not even 10 am on March 2 and already we see over 221k shares of NVAC trading hands.
@ $9.82, that is over $2 million dollars.
Not at the 52 week closing high of $9.83 (just a penny shy), but certainly well above the 52 week low of $9.69 (by a healthy 13 cents; not bad for a SPAC pre-announcement).
NVACR sold 2 shares for a total of 26 cents (which were purchased by me!).
NVACW sold 5,000 shares.
Still holding strong to my belief that the big players are buying up NVAC with the dollars they received by cleaning up and selling off their Rights and Warrants (which they had in their portfolios when NVACU split up into its 3 components back on January 21, 2022.
They, the big players, the capital management companies such as (but not limited to) Yakira Investment Advisers {post #40} and SkyView Investment Advisers {post #42} seem to be CONSOLIDATING to play where the big boys play.
They seem to not want to be bothered with the "penny stock" options portion of this stock, which literally is 70 shares of NVACR or NVACW to 1 share of NVAC.
I am sticking to the belief that the options will have a much greater % swing NORTH, when the acquisition target is announced, than the stock itself.
I'm hoping for a 3x to 5x better return (ie: if NVAC goes from $10 to $20 upon acquisition announcement, a 100% ROI, I myself am hoping NVACR would go from .20 to somewhere between .60 to $1).
I think once a target is announced, the "risk" associated with NVACR is reduced dramatically.
In theory, if one were to hold until the merger is completed, then 10 NVACR would be converted to a share of NVAC, and even if NVAC dropped back down to $10 per share at that time, it still would be a 500% ROI.
Only time will tell.
Last few days I have seen big selling in NVACW and NVACR (with concurrent price drop down to as low as .1280).
Today I see big buying of NVAC (it is only 1:30 pm and 182,517 shares traded so far, and the stock is up 5 cents to $9.84, which is the 52 week high, with the ASK now @ $9.85
Looks to me like big players are getting rid of their rights and warrants in exchange for stock (which has a value of more than 50x of either the stocks or the warrants).
I'm guessing it is just a clean-up and consolidation.
I'm guessing the big players would rather just deal with the one larger piece of the pie (NVAC) rather than the many multiples of the much, much smaller pieces of the same pie (NVACW and NVACR).
Looks like there could be an opportunity for some good buys...
Delay in announcement of Acquisition Target?
As crazy as it sounds, and being as impartial and callous towards recent developments on the other side of the world (and just looking at this in relation to NorthView)...
I believe that the recent developments in the Ukraine (Russian troops crossed the border on 2/23/2022) will post-pone any Press Releases.
Why would a company put out a Press Release now, knowing that such PR would be tremendously overshadowed by current affairs and would dampen whatever was said in such release?
I don't feel that Putin is trying to take over the Ukraine (Why would he? The resources of interest are in the east, and those two provinces have already peacefully acknowledged their desire to leave the Ukraine and rejoin Russia). Rather, I believe Putin is looking to remove the corruption so deeply imbedded in the country and to prevent NATO from being on his border. Keep in mind this is where Hunter Biden was on the board of the Ukrainian energy company (Barisma), which is, btw, currently under Federal Investigation.
https://nypost.com/2022/02/23/hunter-bidens-hot-water-is-reaching-a-boiling-point/
Further, Putin's reason for the invasion is oddly interesting: “We will strive for the demilitarization and de-Nazification of Ukraine, as well as bringing to justice those who committed numerous bloody crimes against civilians.”
Whatever one thinks about Russia/Putin, imagine for a moment what the United States would be willing to risk if we thought for a moment that communist missiles would be just across the border (ie: Ukraine joining NATO).
Actually, you don't have to imagine. Just recall the "Cuban Missile Crisis" and how that crisis almost brought us to the brink of war.
At any rate, let's hope the Russian initiative is short lived, that Putin accomplishes his goals as quickly and with the least amount of blood-shed as possible, and that the Ukraine Crisis settles down quickly - because no matter what, this Administration does not have the strength, commitment, nor worldwide support to stop whatever it is that Putin has intentions of accomplishing.
Any push back now from the US is just going to cause more pain for Americans as well as the rest of the world. Truth be told, the time to stop Putin was months ago. This would never have happened under Trump's watch.
There is also talk of US involvement in 11 biotech labs in the Ukraine, 7 of which were targeted by Russian forces in the 1st day of the invasion. Perhaps Putin is trying to stop the next pandemic...
Bottom line: Let's hope this is short-lived, that Putin gets in with the least amount of blood-shed and accomplishes whatever it is that he wants to protect Russia's sovereignty and security (Putin has said he wants the government of Ukraine and the rest of NATO to agree not to have Ukraine join NATO), and than gets out.
...and...let's further hope China doesn't see what Russia is doing, and then decide it is time to move on Taiwan, because this administration is way too weak to be able to handle pretty much any other crisis in foreign affairs...
Once matters settle down in areas that this Administration unfortunately has absolutely no ability or strength to oppose, the world can get on with trying to become a better place.
Yes, but apparently only "attorneys" are permitted to get an alert when an account is updated.
I believe the alert is called a "bounce."
To sign up as an attorney, and receive "bounce" notifications, when in fact an individual is NOT an attorney, but rather a disgraced disbarred one, would possibly be considered felony fraud.
It is something being investigated at this time...
I wonder if a disgraced and disbarred attorney can get into any trouble by falsifying documents and filing "as an attorney" on Pacer in order to obtain email notifications on the Baltia Whale?
Do you think falsifying information on PACER has any legal ramifications?
...guess we will find out soon enough...
Sentiment is souring:
NVACR has dropped to .16, the lowest I have ever seen it.
NVACW is trading about 100 shares per day, at about .19
NVAC is trading maybe a few hundred to a couple of thousand shares per day at most, at about $9.78
Things are very quiet.
Looks pretty much like most are waiting for something to happen.
I myself am taking an opportunity to sell AXIM in the .20s when I can, and put that back into NVACR at .1601 when the opportunity presents itself.
Otherwise, all quiet on the Western Front.
Good time to start getting my early Spring cleaning started - and by Spring cleaning, I mean prepping the gardens, cleaning out the garage, cutting down dead trees and hanging branches, etc.
I have no dry powder available right now to do anything except sit and wait.
New Purchases by Yakira Capital Management
New Purchase: NorthView Acquisition Corp (NVACU)
Yakira Capital Management, Inc. initiated holding in NorthView Acquisition Corp. The purchase prices were between $10.02 and $10.05, with an estimated average price of $10.03. The stock is now traded at around $10.050000. The impact to a portfolio due to this purchase was 1.25%. The holding were 991,800 shares as of 2021-12-31.
That was almost $10 million.
Yakira Capital Management is a hedge fund company based in Westport, CT. They operate 1 private fund and have approximately $296.2 million in total assets under management (AUM).
So here is what I know:
An EUA can be pulled once the emergency has cleared, but it doesn't necessarily have to be so. However, if the FDA issues and EUA, then they recommend that you immediately file for the 510(k) so that there is the possibility of continuance (non-interruption) once the emergency has cleared.
If you think about Immunopass, the application for the EUA and the application for the 510(K) are pretty much the same thing in that all of the information and test groups, etc. won't really be changing.
I guess, in the case of different variants, the "sauce" used in the test kit will be modified to detect antibodies to different varieties of the virus (assuming the different variations don't all share the same neutralizing antibodies), but this seems to be something that might actually just require an "amendment", since the basic test kit and physicians reader (used by the physician to get quantitative results and easily re-programmed for different test kit applications) will remain the same.
Now to more directly answer your questions: I'm guessing if Axim gets its EUA, it will immediately turn around and apply for the 510(K) with the very same information (if they don't get an EUA, then maybe they need to revise the data they used in the EUA application and apply for a 510(K) using an entirely different set of data, etc.).
As for what would hold up approval of such a clearly beneficial test kit?, I would refer you to my posts as follows and the articles they reference:
#3102 - Talks about how a test (such as Immunopass) could completely change the "politics" behind the pandemic.
#3073 - THIS IS A PROJECT VERITAS EXPOSE': Talks about the corruption inside the FDA, and how "politics" results in some companies (such as Pfizer) getting approvals faster than others, based upon who "greases the palms of the FDA" the most.
Yes, the FDA is supposed to have the public's best interests at heart, but greed and politics clearly and unfortunately take precedent.
HOWEVER, as in post #3102 and the recent exposing of the FDA corruption, perhaps the social pressures to give Immunopass an EUA are beginning to get the attention they deserve.
LOL. Please read the signature that appears at the bottom of my posts.
I guess I should add,
Going back to post #16, here is what I believed would be the result after the split:
Here is something I just stumbled upon while searching for news about NorthView:
New Purchase by SkyView Investment Advisors, LLC: NorthView Acquisition Corp (NVACU)
SkyView Investment Advisors, LLC initiated holding in NorthView Acquisition Corp. The purchase prices were between $10.02 and $10.05, with an estimated average price of $10.03. The stock is now traded at around $10.050000. The impact to a portfolio due to this purchase was 0.47%. The holding were 200,000 shares as of 2021-12-31.
About the investment firm:
Established in 2009, our competitive edge is rooted in the deep experience of our world class, research-driven investment management team. SkyView provides comprehensive multi-asset solutions across traditional and alternative strategies designed to help you manage the complexities of your business and accomplish your goals through:
collaborative relationships built on transparency and open architecture solutions, and partnering to support investments, education, and business development.
In total, Skyview Investment Advisors manages $4,108,296,074 in assets.
They bought Units at $10.03 before the end of 2021. I purchased units in January at $10.09.
Old news, but it is nice to see an investment firm purchasing $2 million worth of NVACU at about the time the SPAC had its IPO.
After the units were split, I myself sold off the warrants and shares and focused entirely upon the Rights.
I kind of figured that the Rights carried the most risk (ie: they would have zero value if a merger is not consummated within 24 months), but I also figured that the founders of NorthView get nothing for their efforts until a merger is completed - so they have the motivation to complete a merger, even a bad one, in order to reap the fruits of their efforts.
As NVACR is for 1/10th of a Right to a share, at about .19 per NVACR, it is the equivalent of paying $1.90 for a share of NVAC, which currently is trading at $9.78.
In other words, even if the SPAC's value remained at $9.78 or even dropped, upon consummation, the Rights would still be looking at a 400% to 500% increase in value.
I just felt that since it was my intention to hold until the announcement of the acquisition target (I could still sell NVACR at that time), or even until just after the merger is completed, that NVACR held the highest risk (minimized by the personal agenda's of NorthView's founders) and therefore the highest rewards.
Its a gamble, but one that hopefully will payoff.
Godspeed.
It was exactly 2 weeks ago, post #2870 and #2871 on February 4th, that I called Dr. Marc Siegel's office and left him a message about Immunopass.
I'm liking Dr. Siegel's push to get this to happen. I think I will call him again...
... and I just did. Left a detailed message.
Here's a nice article that relates to Immunopass, entitled
Well, as for the Rights, I picked up 30k of the 45.6K, all @ .1751
As for NVAC - well, look at that, 418k....almost twice the average volume (222k).
Damn, that's over $4 million! That's surprising!
The warrants are merely 100 traded.
Personally, I saw the units get split into their 3 parts at almost exactly 30 days after the IPO.
NVACU IPO was 12/20/21 - 12/23/21
NVACU split into NVAC, NVACW, NVACR from 1/19/22 (announced) to 1/21/22 (Friday, close of business).
Then, 30 days after that is roughly about 2/18/2022 (today) to about 2/20/2022.
...so I just figured sometime soon might be a good time to announce an acquisition target, and that the number of days left to pick up NVACR at these levels could quickly be running out.
Maybe someone else figured likewise regarding the stock?
...and the pps wouldn't be trading just pennies off the 52-week low...
Sure looks that way.
Fortunately, I got in (in the teens) and got out (in the very low 20s) with the excessive shares I picked up over the last 2 weeks.
I am seriously thinking to do this again if (or should I say when?) AXIM once again closes in on its 52 week low (.131).
I'm guessing we are going to see an uptick in PR activity, based upon the last PR and the information in the most recent 8-k.
There is a reason why AXIM decided to restructure its financial situation and also "cash out" (ie: Axim took on more healthy debt than the toxic debt it retired).
Looks like AXIM is gearing up for something.
Next week is a short week, so I am thinking the next week and the week after is the time to pick up "cheapies", with the anticipation to flip them upon an early March PR (sell on the news).
...but you do know what they say about the "best laid plans"...
Godspeed.
Markets will be closed on Monday, 2/21/2022, Presidents Day (or Washington's Birthday).
In case you missed it:
AXIM BIOTECHNOLOGIES, INC.:
Entry into a Material Definitive Agreement (with 7 insiders to acquire capitol in the total amount of $1,325,000 in exchange for restricted shares, 10 year notes, 3% per annum)
Termination of a Material Definitive Agreement (with GS Capital Partners, LLC, retired toxic financing note for $1,110,000 funds derived from the above 7 notes).
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant (Could relate to the two, short term notes, each for $250,000, 1.5% interest rate, one of them was already paid in full on February 14, 2022 - the other for $250,000 is payable before March 10, 2022.
Here is the article:
https://www.marketscreener.com/quote/stock/AXIM-BIOTECHNOLOGIES-INC-120795169/news/AXIM-BIOTECHNOLOGIES-INC-Entry-into-a-Material-Definitive-Agreement-Termination-of-a-Material-D-39494564/
Project Veritas has FDA Executive Officer Christopher Cole, on video, discussing at length the kickbacks between the FDA and Pfizer.
If anyone doubted the corruption going on within the FDA, then the following videos are a must watch!
Nothing wrong with that what-so-ever.
I have found that when I am able to embrace lower expectations, I am so much better off, and often times surprisingly pleased.
Kind of like when you fully accept that your child is an average student, and then one day they make the honor roll.
Gives you so many more opportunities to celebrate.
It is my personal opinion that you will be pleasantly pleased with AXIM's performance with the DED line, because in truth, when I stated a goal of $2.50 to $3 per share by year-end, I wasn't even considering any input from Immunopass.
Immunopass for me would be an added plus as well.
Godspeed, and thank you for your other post, which I used to change my signature, with a little of my heavy sense of humor thrown in.
Thank you again for a wasted personal attack on a poster here, instead of providing something useful as it relates to AXIM, which I once again gently remind you is the purpose of this board.
No one is interested in reading other posters quibbling.
If you and the others here who constantly attack me ("K", "jH", "T", and even that guy whose alias is simply just a 2 digit number) - instead of intelligently addressing the content of my posts - have some kind of infatuation towards me, I have to tell you to put your feelings aside, as I am completely not interested.
HERE, AXIM gets all of my attention.
This is the last time I will politely ask that you refrain from personal attacks and stick to the subject at hand.
I, too, after this post, will leave you, and "K", and "T" and "2x12" out of any further references in regards to the feeble mindedness of followers, etc.
Again, personal attacks are welcomed on that other board at:
https://investorshub.advfn.com/Baltia-Air-Lines-Inc-Fka-Blta-918
Best of luck in your future endeavors.
My apologies to all here, but I am a substantial part of today's early selling volume (more than half), as I had some shares left over from last week that I picked up under .16, and my other play is selling at 2 cents under its normal asking price.
I just couldn't resist taking a 2 cent gain on each share here and translating it into what I see as a 2 cent gain per share on the other side. I'm sure no one here would blame me ("K", "jH","T"?)
HOWEVER, I am done "manipulating" today's activity, (as both "K", "jH", and "T" see it), so the stock should fall back where is should be trading anytime soon (perhaps after lunchtime).
(You see, unlike "they" give me credit for, my "influence" and "propaganda" on the share price is merely a drop in the bucket, a grain of sand, a moment in time when it comes to the shear magnitude of it all. You know, the sad part is that with all their protesting, it suggests strongly that they are the weak minded that invest based upon what others say on a dime a dozen stock investing board. Clearly followers, not leaders, and clearly following blindly).
Furthermore, I have no more shares that I picked up under 20 cents, so I won't be selling any more AXIM until it steps up to the next level.
Godspeed.
Agreed, but that is just one take by the very few who are Leaders (take the compliment, you clearly stand out from among the rest), not followers, and who can see through all the BS out there and think for themselves.
Keep in mind that the overwhelming majority out there (and even some posters on this very board, such as "K" and "jH") are mere sheep, and don't possess the foresight that you do.
In other words, those videos are a "wake up call" to the followers, the majority, the masses who are led around blindly by their nostrils, and who time and again label all of that "stuff" as right-wing conspiracy theory - until of course, it is made so clear to them, that they can no longer cling to their "we need our political leaders to guide our every day lives in order to survive in this world" way of "thinking".
So many would rather choose to live their lives as simply as bees in a beehive, never thinking for themselves, just doing what others instruct them to do.
Followers, not Leaders.
Those videos are like taking the red pill for the majority of the public.
I personally believe the FDA has a huge amount of "splaining" to do.
I can't wait to see how they plan to squirm and wiggle their way out of this one!
...and of course, what effect that will have on AXIM's requested EUA...
I am wondering what others believe the recent Project Veritas exposure of FDA corruption (as seen in multiple videos taken over a series of different days with Chief Executive Officer Christopher Cole) will have on the future of fair and unbiased treatment for future EUA's?
In the past, I "joked" that Johnny H would have to "belly-up" with $ to pay off the corrupt FDA officials in order to get Immunopass approved (from post #2981, just a few days ago, which btw was mocked by some here):
Thinking about upcoming share price action and the "new" financial position AXIM now finds itself in (ie: replaced toxic, outsider debt held by those who care nothing about AXIM's survivability, with healthy and prudent financing by insiders who care very much about AXIM's prospects and future), if anyone has done what I have done these past few months (averaged down and accumulated way more shares of AXIM then they truly intended to hold), then I believe any upward motion in the pps will be muted somewhat by the sale of those excess shares.
I myself have small ASKS set in place on the way up over the next 60 days to periodically sell my excess shares of AXIM as the pps rises (if it chooses to do so).
I'm further guessing that it will be a slow ride to about what appears to be a general shareholder average (50 cents), but after that, when we have all "dumped" (I use that word because "K" seems to like tossing it around) our excess, we should be back on track, and any further rise could be quite impressive (ie: demand will be in control, and supply will be limited).
I'm not suggesting anything is going to happen any time soon, but if AXIM goes from where it is now to about $2.50 to $3 by the end of this year, I'm sure that any of us who stayed on this rollercoaster ride will be glad we did.
If we can reach $2.50 to $3 by year end, that would be a 500% to 600% ROI for anyone who is averaged in at about 50 cents.
Not a bad return if it can be achieved (and I personally believe that it can be).
Godspeed to All.
Thank you, once again, JaneyH, for your "due diligence" and "witty contribution" to the interests of this board.
You do realize that this board is not about its individual members, but rather about Axim Biotechnologies, don't you?
If you would like to attack me personally, there appears to be another board that has been dedicated to doing just that these last 3 1/2+ years. I have attached a link to that board at the bottom of this post. You can visit them over there. I am sure they will love your presence. They say "misery loves company."
As for now, I would ask that if you do post here, please keep the topic relevant to AXIM and not focused on any individual posters in general.
You see, no one wants to waste time reading petty arguments.
Every one here has a deep interest in the company itself, and would like information on things that effect the company in either a positive or a negative way, so that we can all make good financial decisions that help support the ones we love.
Godspeed.
That other board that will welcome you can be found in the link below.
https://investorshub.advfn.com/Baltia-Air-Lines-Inc-Fka-Blta-918
My thoughts on this 8-k:
(and my apologies, Tex, as I would have addressed this absolute gem of a find last night if I hadn't been so busy yesterday and burned through my daily posting limit).
Generally speaking, all good, and I think that the way we saw the market respond to AXIM's evolution and current position will continue, generally speaking, in a positive direction.
It looks to me that AXIM retired 1.1 million in "toxic" debt (G.S. Capital partners, LLC) held by an outsider with little concern for what happens to AXIM, with actual financing by insiders who, even more so now, have a tremendous stake in the outcome of the company.
Those new notes have an expiration of 10 years, with a very doable interest rate of 3% per year, and a huge incentive for those holding the notes to refrain from cashing them in, as the appreciation in value of the shares that they hold will truly be astronomical.
THAT is what I mean when I say that a Rising Tide raises all Boats.
Sure, the "insiders" may have made a killing with these deals, but we shareholders will be able to ride along with them to success.
I'd personally rather have a smaller piece of a much bigger pot, than a larger piece of no pot at all.
And it is about time.
If anyone was wondering where the selling pressure was coming from these last few months, no doubt it came from the shares being received as interest by G.S. Capital, LLC.
With the final "installment" of 173,390 (albeit restricted) shares, I'm guessing the downward push and large selling volumes have already begun to subside (ie: G.S. Capital has already sold all of its matured shares, and 175k restricted shares retiring per month over the next few months will have little effect on AXIM's pps)..
I believe G.S. Capital, LLC was the primary source of all of the selling volume and pressure.
With the company debt being held by those who care about the company's future, and who have a vested interest in the company's success, we are now in good hands.
If I am right, then AXIM has turned a corner and is heading in a new direction.
Financially, with toxic debt (expensive debt being held by an outsider that has little concern for the success of the company) being replaced by healthy financing (the shares given in exchange for the debt will undoubtedly be held long term by insiders who now have an even bigger stake in the success of the company, and the interest rate on that debt is just 3% per annum), I believe the company is in a much better position.
I think we can truly step away from talk about "survivability" and rather, begin talking about the prospects of "profitability", and just how far those prospects will move the pps.
Godspeed to All.
Project Veritas has FDA Executive Officer Christopher Cole, on video, discussing at length the kickbacks between the FDA and Pfizer.
If anyone doubted the corruption going on within the FDA, then the following videos are a must watch!
LOL, JR, I've mostly been accumulating as AXIM headed downward day after day, since there just wasn't any bounce, but today was a gift that was long over due.
I still have way too many shares of AXIM, but I am going to have to wait till AXIM goes a little higher in order to take advantage of selling them at a gain.
However, with today's gain on AXIM, I picked up over 5,000 shares in my sideways play (NVACR) that could be considered "free-shares", so I'm checking this day off as a success.
Let's hope, generally speaking, this momentum continues.
Nice action today. I believe we who have been taking it on the chin as of late have been needing a day like today. At one point we were up over 70% (and yes, I did sell most of those cheapies I picked up last week in the teens, as I said I would in post #2963):
Today, 1,806,641 shares of AXIM traded, with a dollar value of $387,146.
Could anyone be so foolish as to believe that an unknown poster on a stock board would be able to influence such activity?
No one could be "sheltered" enough or lack the sophistication necessary to read the statement, "A rising tide raises all boats", and then be compelled to either buy or sell AXIM shares based on that expression, could they?
Actually, if they are simple-minded enough to consider that simple phrase as propaganda, then perhaps I stand corrected.
Scary to think that someone who apparently is so easily swayed would have access to a brokerage account.
Look, I know you and the K are having fun, but you seriously don't believe that someone writing on a stock board that is read by perhaps 30 or so people can in any way "manipulate" a stock, do you? Seriously?
Is "A rising tide raises all boats" Propaganda? Really?
Can it even be considered "manipulating" to those of at least average intelligence?
Nobody of at least average intelligence can be feeble minded enough to believe that an ordinary person writing on a stock board could possess such influence - can they?
There are, undoubtedly, hundreds (if not thousands) of people trading AXIM. Nothing you, or I, or anyone else here has to say is going to sway someone to buy or sell, one way or the other, and if someone was foolish enough to do so, it wouldn't change the stock price but a nudge and for a very short time.
Use logic. There are over 136 million shares outstanding, and on the biggest day AXIM has seen in quite some time, just over 1% of those shares traded hands. What percentage of the people who traded AXIM today (or any other day) actually read this board?
It is always best to set aside emotion and engage logic before posting...and it wouldn't hurt to contribute something of value for a change?
I don't believe I have ever seen anything that could be seen as "due diligence" or was derived from even the smallest amount of research?
You know what they say about opinions!
There is no censorship here, nor should there be attempts at "bullying" anyone into remaining silent, but I think most would prefer to hear things of intelligence and value.
Have a good flight. Rest assured there won't be any announcements tomorrow - that would be WAY too soon, and besides, wouldn't give us enough time to get our money's worth from yesterday's treat.
BTW, I know I was having a fun time on Monday, but do you recall my post #2974